202 related articles for article (PubMed ID: 7588758)
1. Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease.
Sticht H; Bayer P; Willbold D; Dames S; Hilbich C; Beyreuther K; Frank RW; Rösch P
Eur J Biochem; 1995 Oct; 233(1):293-8. PubMed ID: 7588758
[TBL] [Abstract][Full Text] [Related]
2. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
3. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.
Shao H; Jao S; Ma K; Zagorski MG
J Mol Biol; 1999 Jan; 285(2):755-73. PubMed ID: 9878442
[TBL] [Abstract][Full Text] [Related]
4. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.
Zagorski MG; Barrow CJ
Biochemistry; 1992 Jun; 31(24):5621-31. PubMed ID: 1610809
[TBL] [Abstract][Full Text] [Related]
5. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
[TBL] [Abstract][Full Text] [Related]
6. Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis.
Sorimachi K; Craik DJ
Eur J Biochem; 1994 Jan; 219(1-2):237-51. PubMed ID: 8306991
[TBL] [Abstract][Full Text] [Related]
7. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
Otvos L; Szendrei GI; Lee VM; Mantsch HH
Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.
Crescenzi O; Tomaselli S; Guerrini R; Salvadori S; D'Ursi AM; Temussi PA; Picone D
Eur J Biochem; 2002 Nov; 269(22):5642-8. PubMed ID: 12423364
[TBL] [Abstract][Full Text] [Related]
9. Nicotine inhibits amyloid formation by the beta-peptide.
Salomon AR; Marcinowski KJ; Friedland RP; Zagorski MG
Biochemistry; 1996 Oct; 35(42):13568-78. PubMed ID: 8885836
[TBL] [Abstract][Full Text] [Related]
10. Structural determinants of the Alzheimer's amyloid beta-peptide.
Soto C; Brañes MC; Alvarez J; Inestrosa NC
J Neurochem; 1994 Oct; 63(4):1191-8. PubMed ID: 7931272
[TBL] [Abstract][Full Text] [Related]
11. 1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence.
Lee JP; Stimson ER; Ghilardi JR; Mantyh PW; Lu YA; Felix AM; Llanos W; Behbin A; Cummings M; Van Criekinge M
Biochemistry; 1995 Apr; 34(15):5191-200. PubMed ID: 7711039
[TBL] [Abstract][Full Text] [Related]
12. Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides.
Chong SH; Yim J; Ham S
Mol Biosyst; 2013 May; 9(5):997-1003. PubMed ID: 23358498
[TBL] [Abstract][Full Text] [Related]
13. Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4.
Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
Eur J Biochem; 1991 Oct; 201(1):61-9. PubMed ID: 1915378
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of the amyloid-beta-peptide using the homology to a fragment of triosephosphate isomerase that forms amyloid in vitro.
Contreras CF; Canales MA; Alvarez A; De Ferrari GV; Inestrosa NC
Protein Eng; 1999 Nov; 12(11):959-66. PubMed ID: 10585501
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of residues 1-28 of the amyloid beta-peptide.
Talafous J; Marcinowski KJ; Klopman G; Zagorski MG
Biochemistry; 1994 Jun; 33(25):7788-96. PubMed ID: 7516706
[TBL] [Abstract][Full Text] [Related]
16. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick D; Soreghan B; Kwon M; Kosmoski J; Knauer M; Henschen A; Yates J; Cotman C; Glabe C
J Biol Chem; 1992 Jan; 267(1):546-54. PubMed ID: 1730616
[TBL] [Abstract][Full Text] [Related]
17. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein.
Fraser PE; Nguyen JT; Inouye H; Surewicz WK; Selkoe DJ; Podlisny MB; Kirschner DA
Biochemistry; 1992 Nov; 31(44):10716-23. PubMed ID: 1420187
[TBL] [Abstract][Full Text] [Related]
18. NMR structure of the water soluble Aβ17-34 peptide.
Fonar G; Samson AO
Biosci Rep; 2014 Nov; 34(6):e00155. PubMed ID: 25284368
[TBL] [Abstract][Full Text] [Related]
19. Molecular structure of a fibrillar Alzheimer's A beta fragment.
Serpell LC; Blake CC; Fraser PE
Biochemistry; 2000 Oct; 39(43):13269-75. PubMed ID: 11052680
[TBL] [Abstract][Full Text] [Related]
20. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase.
Ikura K; Takahata K; Sasaki R
FEBS Lett; 1993 Jul; 326(1-3):109-11. PubMed ID: 8100780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
